0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study

Article de revue

Avec comité de lecture

Yves Dauvilliers, Gary Zammit, Ingo Fietze, David Mayleben, Dalma Seboek Kinter, Scott Pain et Jan Hedner

Sleep (New York, N.Y.), Vol.42(Supplement_1), pp.A152-A153

13/04/2019

Indicateurs

1 Consultations de la notice

Titre: 0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study
Créateurs - sans rôle: Yves Dauvilliers - Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier cedex, France
Gary Zammit - Clinilabs
Ingo Fietze - Charité - Universitätsmedizin Berlin
David Mayleben - CTI Clinical Research Center, Cincinnati, OH, USA
Dalma Seboek Kinter - Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland
Scott Pain - Idorsia Pharmaceuticals Ltd
Jan Hedner - Department of Sleep Medicine, Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
Détails de publication: Sleep (New York, N.Y.), Vol.42(Supplement_1), pp.A152-A153
Identifiants: 99139935809311
Unité académique: Institut des Neurosciences de Montpellier - INM
Langue: English
Type de ressource: Journal article